Who owns Ariad Pharmaceuticals?

Key details on Ariad Pharmaceuticals (Ticker: ARIA)

Who owns Ariad Pharmaceuticals?

Is ARIA a good stock to own? Find out who bought Ariad Pharmaceuticals, who sold Ariad Pharmaceuticals (ARIA) stock, and who holds a large position in Ariad Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
PUTNAM INVESTMENTS 15.68M $97.97M Dec. 31, 2015
Sarissa Capital Management 12.85M $80.31M Dec. 31, 2015
Vanguard 12.15M $76.03M Dec. 31, 2015
Artisan Partners Limited Partnership 9.80M $171.37M June 30, 2013
Westfield Capital Management Company 9.49M $59.33M Dec. 31, 2015
GOLDMAN SACHS 8.46M $155.75M Sept. 30, 2013
BlackRock Fund Advisors 8.00M $49.98M Dec. 31, 2015
STATE STREET CORPORATION 6.89M $43.04M Dec. 31, 2015
Slate Path Capital 6.62M $53.36M March 31, 2014
FMR 6.36M $39.75M Dec. 31, 2015
Discovery Capital Management 5.84M $48.14M March 31, 2015
Waddell & Reed Financial 5.75M $105.87M Sept. 30, 2013
Adage Capital Partners GP 5.61M $35.08M Dec. 31, 2015
Ameriprise Financial 5.46M $100.41M Sept. 30, 2013
Neuberger Berman 5.44M $100.07M Sept. 30, 2013
Camber Capital Management 5.41M $33.78M Dec. 31, 2015
Sectoral Asset Management 5.29M $92.57M June 30, 2013
Columbia Wanger Asset Management 5.29M $97.35M Sept. 30, 2013
Franklin Resources 5.04M $32.09M June 30, 2014
S.A.C. Capital Advisors 4.94M $119.62M Sept. 30, 2012
T. Rowe Price Associates 4.77M $86.34M March 31, 2013
Damian Sousa 4.54M $84.80M Sept. 30, 2013
BlackRock Institutional Trust Company, N.A. 4.52M $28.26M Dec. 31, 2015
Renaissance Technologies 4.40M $28.03M June 30, 2014
PointState Capital 4.25M $26.56M Dec. 31, 2015
Janus Capital Management 4.20M $73.39M June 30, 2013
AQR Capital Management 3.88M $24.73M June 30, 2014
BB Biotech AG 3.69M $67.88M Sept. 30, 2013
Barclays 3.67M $58.60M March 31, 2012
SUSQUEHANNA INTERNATIONAL 3.61M $19.50M Sept. 30, 2014
TimesSquare Capital Management 3.59M $62.87M June 30, 2013

Who sold Ariad Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Jennison Associates March 31, 2011 3.59M $27.00M